FDA Is a No Show at Congressional Hearing on Inspections of Foreign Drug Plants

The FDA did not attend a House Energy and Commerce subcommittee hearing Tuesday focused on why the agency has stalled out on its pre-pandemic efforts to improve inspections of overseas manufacturers that supply drugs to the U.S.
Source: Drug Industry Daily